Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Clover Health Stock Isn’t the Insurance-Disrupting Play You Might Have Thought

Traders are still hoping for another short squeeze in CLOV stock. But the odds of that happening are getting dimmer.

Sesen’s Last Remaining Hope Is a Short Squeeze

Sesen has cash and some short squeeze potential. But with its lead drug facing regulatory setbacks, SESN stock is a gamble at best.

Carnival’s Slow Recovery Will Limit the Gains of CCL Stock

Carnival Cruise Line got through the worst of the pandemic in one piece. But it will take a lot more than that to lift CCL stock much higher.

Rocket Lab Stock Worth Considering Despite Being Slow to Launch

RKLB stock didn't get off to the most auspicious start as a publicly traded company, but the bullish argument is compelling.

Why It Isn’t Time to Give Up on ContextLogic Just Yet

ContextLogic's long losing streak continues, as WISH stock has tumbled. But bears may be overstaying their welcome.